EVOLENT HEALTH INC's ticker is EVH and the CUSIP is 30050B101. A total of 219 filers reported holding EVOLENT HEALTH INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,661,000 | -31.7% | 1,162,708 | -24.0% | 0.04% | -24.5% |
| Q2 2023 | $46,336,000 | +4.2% | 1,529,239 | +11.6% | 0.05% | 0.0% |
| Q1 2023 | $44,480,000 | +43.1% | 1,370,717 | +23.8% | 0.05% | +43.2% |
| Q4 2022 | $31,080,000 | -40.6% | 1,106,832 | -23.9% | 0.04% | -42.2% |
| Q3 2022 | $52,321,000 | +43.8% | 1,454,696 | +22.8% | 0.06% | +56.1% |
| Q2 2022 | $36,378,000 | +133.8% | 1,184,568 | +145.9% | 0.04% | +241.7% |
| Q1 2022 | $15,558,000 | +106.5% | 481,669 | +76.9% | 0.01% | +100.0% |
| Q4 2021 | $7,534,000 | +167.5% | 272,291 | +199.7% | 0.01% | +200.0% |
| Q3 2021 | $2,816,000 | +6.5% | 90,858 | -27.4% | 0.00% | 0.0% |
| Q2 2021 | $2,643,000 | +4.5% | 125,139 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $2,528,000 | +46.9% | 125,139 | +16.6% | 0.00% | +33.3% |
| Q4 2020 | $1,721,000 | +19.8% | 107,304 | -7.3% | 0.00% | +50.0% |
| Q3 2020 | $1,436,000 | +47.3% | 115,735 | -15.5% | 0.00% | 0.0% |
| Q2 2020 | $975,000 | +34.5% | 136,908 | +2.6% | 0.00% | +100.0% |
| Q1 2020 | $725,000 | -36.3% | 133,468 | +6.2% | 0.00% | -50.0% |
| Q4 2019 | $1,138,000 | +4.0% | 125,707 | -17.3% | 0.00% | 0.0% |
| Q3 2019 | $1,094,000 | -58.0% | 152,093 | -53.6% | 0.00% | +100.0% |
| Q2 2019 | $2,607,000 | +42.7% | 328,023 | +125.8% | 0.00% | -66.7% |
| Q1 2019 | $1,827,000 | -72.6% | 145,264 | -56.5% | 0.00% | -76.9% |
| Q4 2018 | $6,667,000 | -22.9% | 334,171 | +9.8% | 0.01% | -7.1% |
| Q3 2018 | $8,643,000 | +80.1% | 304,338 | +33.5% | 0.01% | +75.0% |
| Q2 2018 | $4,799,000 | +108.4% | 227,993 | +41.1% | 0.01% | +100.0% |
| Q1 2018 | $2,303,000 | +6.4% | 161,622 | -8.2% | 0.00% | 0.0% |
| Q4 2017 | $2,165,000 | 0.0% | 176,012 | +44.7% | 0.00% | 0.0% |
| Q3 2017 | $2,165,000 | +5.8% | 121,642 | +50.7% | 0.00% | 0.0% |
| Q2 2017 | $2,046,000 | +3.1% | 80,725 | -9.3% | 0.00% | 0.0% |
| Q1 2017 | $1,985,000 | +18.6% | 89,012 | -21.2% | 0.00% | +33.3% |
| Q4 2016 | $1,673,000 | -28.7% | 113,011 | +18.6% | 0.00% | -40.0% |
| Q3 2016 | $2,346,000 | -41.9% | 95,293 | -54.7% | 0.01% | +25.0% |
| Q2 2016 | $4,038,000 | – | 210,320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 795,000 | $14,151,000 | 4.00% |
| FORMULA GROWTH LTD | 803,500 | $14,302,000 | 2.25% |
| 1492 Capital Management LLC | 100,513 | $1,789,000 | 1.58% |
| SECTORAL ASSET MANAGEMENT INC | 652,680 | $11,618,000 | 1.50% |
| ACUTA CAPITAL PARTNERS, LLC | 450,000 | $8,010,000 | 1.44% |
| Elk Creek Partners, LLC | 1,173,823 | $20,894,000 | 1.32% |
| Tygh Capital Management, Inc. | 297,994 | $5,304,000 | 1.06% |
| White Pine Investment CO | 99,250 | $1,767,000 | 0.94% |
| Tamarack Advisers, LP | 75,000 | $1,335,000 | 0.82% |
| CADIAN CAPITAL MANAGEMENT, LP | 940,000 | $16,732,000 | 0.78% |